CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 184 filers reported holding CLOVIS ONCOLOGY INC in Q2 2015. The put-call ratio across all filers is 1.20 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $5,280,000 | +22.8% | 118,871 | -0.3% | 0.01% | +20.0% |
| Q3 2016 | $4,300,000 | +166.9% | 119,281 | +1.6% | 0.01% | +150.0% |
| Q2 2016 | $1,611,000 | -11.7% | 117,450 | +23.6% | 0.00% | 0.0% |
| Q1 2016 | $1,824,000 | -44.2% | 95,001 | +1.7% | 0.00% | -50.0% |
| Q4 2015 | $3,270,000 | -66.8% | 93,422 | -12.8% | 0.00% | -69.2% |
| Q3 2015 | $9,847,000 | +14.3% | 107,076 | +9.2% | 0.01% | +18.2% |
| Q2 2015 | $8,618,000 | +43.1% | 98,067 | +20.9% | 0.01% | +37.5% |
| Q1 2015 | $6,021,000 | +25.0% | 81,119 | -5.7% | 0.01% | +33.3% |
| Q4 2014 | $4,815,000 | +22.8% | 85,989 | -0.5% | 0.01% | +20.0% |
| Q3 2014 | $3,921,000 | +40.4% | 86,451 | +28.2% | 0.01% | +25.0% |
| Q2 2014 | $2,792,000 | -18.6% | 67,419 | +36.1% | 0.00% | -20.0% |
| Q1 2014 | $3,430,000 | +15.8% | 49,523 | +0.7% | 0.01% | +25.0% |
| Q4 2013 | $2,963,000 | +8.6% | 49,166 | +9.6% | 0.00% | -20.0% |
| Q3 2013 | $2,728,000 | +6.8% | 44,874 | +17.7% | 0.01% | 0.0% |
| Q2 2013 | $2,555,000 | – | 38,139 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 150,000 | $1,564,000 | 4.60% |
| Healthcare Value Capital, LLC | 100,000 | $1,043,000 | 3.07% |
| Palo Alto Investors LP | 5,056,286 | $52,712,000 | 2.90% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 1,328,200 | $13,848,000 | 1.53% |
| Ikarian Capital, LLC | 513,700 | $5,355,000 | 0.87% |
| Pinz Capital Management, LP | 207,800 | $2,166,000 | 0.79% |
| Leap Investments LP | 146,300 | $1,525,000 | 0.72% |
| Elk Creek Partners, LLC | 574,616 | $5,990,000 | 0.69% |
| SECTOR GAMMA AS | 408,625 | $4,260,000 | 0.68% |
| Artal Group S.A. | 1,000,000 | $10,425,000 | 0.40% |